BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 10961691)

  • 1. ATP-binding domain of NTPase/helicase as a target for hepatitis C antiviral therapy.
    Borowski P; Mueller O; Niebuhr A; Kalitzky M; Hwang LH; Schmitz H; Siwecka MA; Kulikowsk T
    Acta Biochim Pol; 2000; 47(1):173-80. PubMed ID: 10961691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the helicase activity of HCV NTPase/helicase by 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide-5 '-triphosphate (ribavirin-TP).
    Borowski P; Lang M; Niebuhr A; Haag A; Schmitz H; Schulze zur Wiesch J; Choe J; Siwecka MA; Kulikowski T
    Acta Biochim Pol; 2001; 48(3):739-44. PubMed ID: 11833782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus NS3 NTPase/helicase: different stereoselectivity in nucleoside triphosphate utilisation suggests that NTPase and helicase activities are coupled by a nucleotide-dependent rate limiting step.
    Locatelli GA; Gosselin G; Spadari S; Maga G
    J Mol Biol; 2001 Nov; 313(4):683-94. PubMed ID: 11697897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of the NTPase/helicases of hepatitis C and related Flaviviridae viruses.
    Bretner M; Najda A; Podwińska R; Baier A; Paruch K; Lipniacki A; Piasek A; Borowski P; Kulikowski T
    Acta Pol Pharm; 2004 Dec; 61 Suppl():26-8. PubMed ID: 15909930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Halogenated benzimidazoles and benzotriazoles as inhibitors of the NTPase/helicase activities of hepatitis C and related viruses.
    Borowski P; Deinert J; Schalinski S; Bretner M; Ginalski K; Kulikowski T; Shugar D
    Eur J Biochem; 2003 Apr; 270(8):1645-53. PubMed ID: 12694177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ring-expanded ("fat") nucleoside and nucleotide analogues exhibit potent in vitro activity against flaviviridae NTPases/helicases, including those of the West Nile virus, hepatitis C virus, and Japanese encephalitis virus.
    Zhang N; Chen HM; Koch V; Schmitz H; Liao CL; Bretner M; Bhadti VS; Fattom AI; Naso RB; Hosmane RS; Borowski P
    J Med Chem; 2003 Sep; 46(19):4149-64. PubMed ID: 12954067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nucleotide triphosphatase/helicase of hepatitis C virus as a target for antiviral therapy.
    Borowski P; Schalinski S; Schmitz H
    Antiviral Res; 2002 Sep; 55(3):397-412. PubMed ID: 12206878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical properties of a minimal functional domain with ATP-binding activity of the NTPase/helicase of hepatitis C virus.
    Borowski P; Kuehl R; Mueller O; Hwang LH; Schulze Zur Wiesch J; Schmitz H
    Eur J Biochem; 1999 Dec; 266(3):715-23. PubMed ID: 10583365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization and mutational analysis of the helicase and NTPase activities of hepatitis C virus full-length NS3 protein.
    Wardell AD; Errington W; Ciaramella G; Merson J; McGarvey MJ
    J Gen Virol; 1999 Mar; 80 ( Pt 3)():701-709. PubMed ID: 10092010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and evaluation of ATP-binding site directed potential inhibitors of nucleoside triphosphatases/helicases and polymerases of hepatitis C and other selected Flaviviridae viruses.
    Bretner M; Schalinski S; Haag A; Lang M; Schmitz H; Baier A; Behrens SE; Kulikowski T; Borowski P
    Antivir Chem Chemother; 2004 Jan; 15(1):35-42. PubMed ID: 15074713
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NTPase/helicase of Flaviviridae: inhibitors and inhibition of the enzyme.
    Borowski P; Niebuhr A; Schmitz H; Hosmane RS; Bretner M; Siwecka MA; Kulikowski T
    Acta Biochim Pol; 2002; 49(3):597-614. PubMed ID: 12422230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potent inhibition of NTPase/helicase of the West Nile Virus by ring-expanded ("fat") nucleoside analogues.
    Zhang N; Chen HM; Koch V; Schmitz H; Minczuk M; Stepien P; Fattom AI; Naso RB; Kalicharran K; Borowski P; Hosmane RS
    J Med Chem; 2003 Oct; 46(22):4776-89. PubMed ID: 14561097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Specific targeting of hepatitis C virus NS3 RNA helicase. Discovery of the potent and selective competitive nucleotide-mimicking inhibitor QU663.
    Maga G; Gemma S; Fattorusso C; Locatelli GA; Butini S; Persico M; Kukreja G; Romano MP; Chiasserini L; Savini L; Novellino E; Nacci V; Spadari S; Campiani G
    Biochemistry; 2005 Jul; 44(28):9637-44. PubMed ID: 16008349
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and characterization of West Nile virus nucleoside triphosphatase (NTPase)/helicase: evidence for dissociation of the NTPase and helicase activities of the enzyme.
    Borowski P; Niebuhr A; Mueller O; Bretner M; Felczak K; Kulikowski T; Schmitz H
    J Virol; 2001 Apr; 75(7):3220-9. PubMed ID: 11238848
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The RNA helicase, nucleotide 5'-triphosphatase, and RNA 5'-triphosphatase activities of Dengue virus protein NS3 are Mg2+-dependent and require a functional Walker B motif in the helicase catalytic core.
    Benarroch D; Selisko B; Locatelli GA; Maga G; Romette JL; Canard B
    Virology; 2004 Oct; 328(2):208-18. PubMed ID: 15464841
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
    Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
    HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities.
    Ivanov KA; Ziebuhr J
    J Virol; 2004 Jul; 78(14):7833-8. PubMed ID: 15220459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of an Escherichia coli RNA polymerase-associated NTPase.
    Butzow JJ; Garland C; Van Lee L; Eichhorn GL
    Biochemistry; 1997 Dec; 36(48):14794-8. PubMed ID: 9398200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Searching for a new anti-HCV therapy: synthesis and properties of tropolone derivatives.
    Boguszewska-Chachulska AM; Krawczyk M; Najda A; Kopańska K; Stankiewicz-Drogoń A; Zagórski-Ostoja W; Bretner M
    Biochem Biophys Res Commun; 2006 Mar; 341(2):641-7. PubMed ID: 16438939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tropolone and its derivatives as inhibitors of the helicase activity of hepatitis C virus nucleotide triphosphatase/helicase.
    Borowski P; Lang M; Haag A; Baier A
    Antivir Chem Chemother; 2007; 18(2):103-9. PubMed ID: 17542155
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.